Patients harboring ALK rearrangement adenocarcinoma after acquired resistance to crizotinib and transformation to small-cell lung cancer: a case report

Patients harboring ALK rearrangement adenocarcinoma after acquired resistance to crizotinib and transformation to small-cell lung cancer: a case report

You-cai Zhu,1 Xing-hui Liao,2 Wen-xian Wang,3 Chun-wei Xu,4 Wu Zhuang,5 Li-hua Zhong,4 Kai-qi Du,1 Yan-ping Chen,4 Gang Chen,4 Mei-yu Fang6 1Department of Chest Disease Diagnosis and Treatment Center, 2Department of Tumor Molecular Laboratory, Zhejiang Rongjun Hospital, Jiaxing, Zhejiang, 3Departme...

Full description

Bibliographic Details
Main Authors: Zhu Y, Liao X, Wang W, Xu C, Zhuang W, Zhong L, Du K, Chen Y, Chen G, Fang M
Format: Article
Language:English
Published: Dove Medical Press 2017-06-01
Series:OncoTargets and Therapy
Subjects:
lung cancer
ALK
crizotinib
small-cell lung cancer
Online Access:https://www.dovepress.com/patients-harboring-alk-rearrangement-adenocarcinoma-after-acquired-res-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/patients-harboring-alk-rearrangement-adenocarcinoma-after-acquired-res-peer-reviewed-article-OTT

Similar Items